We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Partners Group has agreed to acquire a European pharmaceutical company, Pharmathen, from the international investment firm BC Partners for an enterprise value of approximately $1.9bn (€1.6bn).